• H2 Medical Technologies®
  • News & Media
  • Contact
  • H2 Global Group
  • Pathology

    Czech Breakthrough in Medicine: H2 Global Group Receives Regulatory Approval for Hydrogen Clinical Study — New Era in Alzheimer’s Therapy Begins

    roman.stetina

    ·

    Úno 2, 2024
  • Endocrinologist, Neurologist

    Czech Innovation Against Alzheimer’s: H2 Global Group Enters a Key Growth Phase

    Matěj Žárský

    ·

    Úno 2, 2024
  • Pathology

    Czech MedTech Startup H2 Medical Technologies Unveils World’s First Patented Hydrogen-Based Therapy with the Potential to Target Alzheimer’s Disease

    Matěj Žárský

    ·

    Úno 2, 2024

Archive

  • Únor 2024

Categories

  • Endocrinologist
  • Neurologist
  • Pathology

Recent Posts

  • Czech Breakthrough in Medicine: H2 Global Group Receives Regulatory Approval for Hydrogen Clinical Study — New Era in Alzheimer’s Therapy Begins2 února, 2024
  • Czech Innovation Against Alzheimer’s: H2 Global Group Enters a Key Growth Phase2 února, 2024
  • Czech MedTech Startup H2 Medical Technologies Unveils World’s First Patented Hydrogen-Based Therapy with the Potential to Target Alzheimer’s Disease2 února, 2024

Tags

Doctor Nurse patient

Social Links

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
H2 Medical Technologies®

A key division dedicated to the research, development, production, and servicing of innovative hydrogen devices.

We collaborate with leading international research and educational institutions, enabling us to deliver cutting-edge solutions at the forefront of science and innovation. Our mission is to provide effective, user-friendly, and highly functional solutions in areas where molecular hydrogen has become essential.

With its well-documented benefits, molecular hydrogen is at the heart of our work. Our team leverages its unique properties to develop innovative solutions in various forms, tailored to specific needs with maximum efficiency.

Copyright © 2025 ·

H2 Medical Technologies®

· All rights reserved

· info@H2Medical.com